bannerparasol
santen
Шахматы
YouTube
glaucoma_net_ru
facebook
ВК
oftalmolog_club
Первая пятница декабря
Beaver
varthamana2
appstore
Mobile
АйНьюс.РФ
eye5
профессор
Основные мероприятия ассоциации офтальмологов
askin_heid
www.worldglaucoma.org
Торика
Ассоциации
Флаги
medlab
Конгресс 2014
Конгресс
Новости офтальмологии
Steven Vold, MD, trades his typical interviewer seat with Robert Weinstock, MD, to discuss the evolving state of microinvasive glaucoma surgery (MIGS). Dr. Vold provides insight into new devices and recent acquisitions that will bring MIGS to the next level for physicians and patients. The two surgeons discuss how ophthalmologists should prepare for this new era of glaucoma surgery
BACKGROUND: Primary angle-closure glaucoma is a leading cause of irreversible blindness worldwide. In early-stage disease, intraocular pressure is raised without visual loss. Because the crystalline lens has a major mechanistic role, lens extraction might be a useful initial treatment.
Уважаемые коллеги, Приглашаем вас принять участие в V международном симпозиуме "Проблемные вопросы глаукомы", который состоится 12.11 в Президент-отеле (Москва).
Background: Endophthalmitis, which can occur after ophthalmic surgery, is an inflammation of the intraocular cavity and causes temporary or permanent vision impairment. However, little is known about the cost of treatment. The objective of this analysis was to update and expand upon the results of a previously published report that estimated the direct medical cost of treatment for endophthalmitis.
Оптическая индустрия готовится к Третьей церемонии вручения премии «Золотой лорнет 2017», которая пройдет в рамках 20-й Московской международной оптической выставки MIOF в МВЦ «Крокус Экспо» 15 февраля 2017 года.
Республиканская конференция с международным участием «Актуальные вопросы офтальмологии» пройдет 9-10 декабря 2016 года в г. Минске на базе Белорусской медицинской академии последипломного образования по адресу: г. Минск, ул. П. Бровки, 3, корп. 3.
OBJECTIVE: To assess the efficiency of alternative monitoring services for people with ocular hypertension (OHT), a glaucoma risk factor
Hybrid angiography The SPECTRALIS platform offers a unique combination of non-invasive OCT angiography with dye-based, gold-standard fluorescein (FA) or indocyanine green (ICGA) scanning laser angiography. With this hybrid angiography approach, OCTA images can be directly correlated pixel to pixel to FA or ICGA, setting a baseline for subsequent OCTA-only follow-up examinations. The Scan Planning Tool automates OCTA scan placement on a region of interest identified on FA/ICGA or any other previously-acquired cSLO image. Such reference images can originate from the same or another SPECTRALIS device.
До 20 декабря можно отправить заявку Scientific Sessions: Introduction to Swept Source OCT and SS OCT Angiography The Unmet Medical Need in nAMD: How Advancements in Imaging Technologies Will Guide Future Therapies (Sponsored by Novartis) Retinal Vascular Disease AMD (I) Myopia Other Pathologies CNV in CSR – Case Presentations and Roundtable Cortical Vitreous and Vitreoretinal Imaging Optic Nerve and Glaucoma AMD (II) Rapid Fire Uveitis, Choroidal Imaging and Tumors
Can electrostimulation of the ciliary muscle delay the loss of accommodation experienced in early presbyopia?
Dear member, The World Glaucoma Association is affiliated 83 glaucoma societies worldwide. As a result, the WGA is able to offer you, a number of their services. By clicking here you will be able to download the WGA flyer, describing all details.
It is our pleasure to invite you to participate in the upcoming European Symposium on The New Agreed Draft Regulations on Medical Devices – (RMD2016) which will take place 7-8 November 2016, at the Hilton Prague in Prague, Czech Republic.
SIXTY-SECOND DIALOGUE Initiating a conversation about hereditary factors with my patients takes 60 seconds. Here is what I say: “Mrs. Jones, we are trying to make sure that our glaucoma patients are aware of the hereditary component of glaucoma.
Indications and Usage ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic suspension) is a topical anti-infective and corticosteroid combination for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.
Spectralis® OCT-Ангиография (OCT-A) для диагностической платформы Spectralis® была представлена на ежегодном съезде Американской Академии Офтальмологии (ААО)
At a Glance Taking an idea and turning it into reality can be an incredibly long and arduous journey There are a number of pitfalls you need to avoid – IP, finance and competitors John Marshall has invented and pioneered many technologies in eyecare and beyond – he’s far more than the inventor of the excimer laser Here, he shares his insights and his stories of innovation
Голосование
Что "заставляет" Вас заниматься научными исследованиями?
Популярная пресса
Фотогалерея
Интересное видео
Книги-новинки
Клуб молодых офтальмологов

МОО "Глаукомное общество"

Экспертный совет по глаукоме

Школа офтальмолога

Новостная лента на Twitter
Новости зарубежной офтальмологии